NDC 51672-4172-01 - Felbamate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4172
- Requested NDC
- 51672-4172-01
- Package NDCs from labels
- 51672-4172-1, 51672-4172-9, 51672-4172-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Felbamate Oral Suspension USP 600 mg/5 mL | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4172-1 | Felbamate | 237 mL in 1 BOTTLE | SUSPENSION | 237 | 3 | |
| 51672-4172-9 | Felbamate | 473 mL in 1 BOTTLE | SUSPENSION | 473 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4172 | FELBAMATE SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.] | 3 | Current NDC, Legacy NDC, 2 package rows | 20170623_0afffb17-e6ac-4bea-a90e-7ef3c8150290.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4172-1 | ML - Milliliter | 51672-4172 | b9e234bf-bcb9-4c4b-a0e0-f5f48955ad08 | 1 | 2017-07-07 |
| 51672-4172-9 | ML - Milliliter | 51672-4172 | 2c09f0b8-bb48-4a6d-8f69-7eebafb066ed | 1 | 2017-07-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Daily Moisturizing | DIMETHICONE | Retail Business Services, LLC | c8a876e2-0a34-4c3d-a0bc-549dd3048e8a | 2026-02-06 | Warnings, Adverse reactions | 92RU3N3Y1O |
| Daily Moisturizing | DIMETHICONE | Publix Super Markets, Inc. | 28ac9de4-2a63-4839-bed5-9bcc59ebeb2a | 2026-02-05 | Warnings, Adverse reactions | 92RU3N3Y1O |
| Daily Moisturizing | DIMETHICONE | Lidl US, LLC | c82f236d-c27f-458c-bcd8-19877d09e9a3 | 2026-02-04 | Warnings, Adverse reactions | 92RU3N3Y1O |
| Daily Moisturizing | DIMETHICONE | Lidl US, LLC | 5e83811f-773f-43e7-bab8-f9e558fb0e00 | 2026-02-04 | Warnings, Adverse reactions | 92RU3N3Y1O |
| Daily Moisturizing | DIMETHICONE | CVS Pharmacy, Inc. | edc20df4-561e-486f-b9f1-900672a0f2a4 | 2026-02-03 | Warnings, Adverse reactions | 92RU3N3Y1O |
| Thera Plus Vitamin A and D Cream | DIMETHICONE, ZINC OXIDE | FOURSTAR GROUP USA, INC. | 36f09fa4-a3b8-4104-9745-ee60aa493b06 | 2026-02-02 | Warnings | 92RU3N3Y1O |
| Gas Relief Ultimate Strength Softgels | SIMETHICONE | Advanced Rx LLC | 5d412711-efd3-4b27-bfde-6fee2f460f8b | 2026-02-01 | Warnings | 92RU3N3Y1O |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Cracked Heel Repair Balm | DIMETHICONE | Delta Brands Inc. | 42b7c9f8-0557-8e33-e063-6394a90a5919 | 2026-01-30 | Warnings | 92RU3N3Y1O |
| Readybath TPC Total Perineal Care | DIMETHICONE | Medline Industries, Inc. | 43a3f0f7-f76f-434d-a21f-7eaa3638913d | 2026-01-30 | Warnings | 92RU3N3Y1O |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 2968PHW8QP |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| TheraCare Diabetic Foot Cream | DIMETHICONE, PETROLATUM | Veridian Healthcare | 49132a75-4a16-cede-e063-6294a90a6217 | 2026-01-29 | Warnings | 92RU3N3Y1O |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.